Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM P/E Multiple | -13.1x - -14.5x | -13.8x |
Selected Fwd P/E Multiple | 1.1x - 1.3x | 1.2x |
Fair Value | kr2.03 - kr2.25 | kr2.14 |
Upside | 36.0% - 50.4% | 43.2% |
Benchmarks | - | Full Ticker |
Evolear AB (publ) | - | NGM:EVOL |
Scandinavian ChemoTech AB (publ) | - | OM:CMOTECB |
Xvivo Perfusion AB (publ) | - | OM:XVIVO |
Odinwell AB | - | NGM:ODIN |
Fluicell AB (publ) | - | OM:FLUI |
Vibrosense Dynamics AB (publ) | - | XSAT:VSDB |
- | - | - |
Select Price / LTM EPS Ratio | ||||||||
Benchmark Companies | ||||||||
EVOL | CMOTEC B | XVIVO | ODIN | FLUI | VSD B | |||
NGM:EVOL | OM:CMOTECB | OM:XVIVO | NGM:ODIN | OM:FLUI | XSAT:VSDB | |||
Historical Net Income Growth | ||||||||
5Y CAGR | NM- | NM- | 103.5% | NM- | NM- | NM- | ||
3Y CAGR | NM- | NM- | 176.4% | NM- | NM- | NM- | ||
Latest Twelve Months | -99.2% | 28.2% | -7.8% | 16.9% | 64.4% | 26.9% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | -187.4% | -1491.8% | 3.9% | -137.5% | -747.6% | -476.7% | ||
Prior Fiscal Year | -197.0% | -747.4% | 15.4% | -130.6% | -795.5% | -409.7% | ||
Latest Fiscal Year | -467.7% | -208.9% | 20.9% | -110.3% | -290.0% | -297.8% | ||
Latest Twelve Months | -543.3% | -179.9% | 13.5% | -117.7% | -134.7% | -197.1% | ||
Current Trading Multiples | ||||||||
EV / LTM EBITDA | 6.3x | -3.7x | 71.3x | -2.4x | -0.2x | -7.1x | ||
Price / LTM Sales | 3.3x | 6.0x | 8.5x | 3.6x | 1.6x | 17.1x | ||
LTM P/E Ratio | -0.6x | -3.3x | 62.8x | -3.0x | -1.2x | -8.7x | ||
Low | Mid | High | ||||||
Benchmark LTM P/E Ratio | -3.3x | -1.2x | 62.8x | |||||
Historical LTM P/E Ratio | -20.5x | -14.1x | -2.9x | |||||
Selected P/E Multiple | -13.1x | -13.8x | -14.5x | |||||
(x) LTM Net Income | (6) | (6) | (6) | |||||
(=) Equity Value | 73 | 77 | 80 | |||||
(/) Shares Outstanding | 32.8 | 32.8 | 32.8 | |||||
Implied Value Range | 2.22 | 2.34 | 2.45 | |||||
FX Rate: SEK/SEK | 1.0 | 1.0 | 1.0 | Market Price | ||||
Implied Value Range (Trading Cur) | 2.22 | 2.34 | 2.45 | 1.50 | ||||
Upside / (Downside) | 48.6% | 56.4% | 64.2% |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | EVOL | CMOTEC B | XVIVO | ODIN | FLUI | VSD B | |
Value of Common Equity | 6 | 46 | 6,810 | 15 | 12 | 49 | |
(/) Shares Outstanding | 4.5 | 23.3 | 31.5 | 39.6 | 1.4 | 32.8 | |
Implied Stock Price | 1.40 | 1.98 | 216.20 | 0.37 | 8.55 | 1.50 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 1.40 | 1.98 | 216.20 | 0.37 | 8.55 | 1.50 | |
Trading Currency | SEK | SEK | SEK | SEK | SEK | SEK | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |